Profiel
Michael N.
Chang was the founder of Pharmanex, Inc., founded in 1994, where the title held was Chief Science Officer, SVP-Research & Development.
Dr. Chang was the founder of Optimer Pharmaceuticals LLC, founded in 1998, where the title held was Director from 1998 to 2013.
Dr. Chang was the founder of OBI Pharma, Inc., founded in 2002, where the title held was Chairman & Spokesman.
Former jobs include Director-Drug Development Division at Rhone-Poulenc Rorer, Inc., Deputy Director-Pharmaceutical Chemistry at Merck Sharp & Dohme (I.A.) Corp.
(Taiwan), Director at Ansun Biopharma, Inc., Vice President-Pharmaceutical Department at ArQule, Inc., Chief Scientific Officer at Nu Skin Enterprises, Inc. from 1998 to 2000, and Partner at Delos Advisors Ltd. Education includes a doctorate from Brandeis University and an undergraduate degree from Fu Jen Catholic University.
Eerdere bekende functies van Michael Chang
| Bedrijven | Functie | Einde |
|---|---|---|
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Algemeen Directeur | 05-05-2010 |
| NU SKIN ENTERPRISES, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2000 |
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Bestuurslid | - |
Delos Advisors Ltd.
Delos Advisors Ltd. Investment ManagersFinance Delos Capital invests in companies located in Greater China and in the United States. The firm targets companies operating in the fields of life sciences, therapeutics and medtech devices sectors. It provides financing for buyout, direct or indirect private equity investments, restructuring, recapitalizations, strategic investments and growth stage capital requirements. It also makes investments in public listed companies. | Private Equity Investor | - |
Merck Sharp & Dohme (I.A.) Corp. (Taiwan) | Corporate Officer/Principal | - |
Opleiding van Michael Chang
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 11 |
|---|---|
ArQule, Inc.
ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Nu Skin Enterprises, Inc.
Nu Skin Enterprises, Inc. Household/Personal CareConsumer Non-Durables Develops and distributes personal care products and nutritional supplements | Consumer Non-Durables |
Rhone-Poulenc Rorer, Inc.
Rhone-Poulenc Rorer, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and markets human pharmaceuticals | Health Technology |
Brandeis University
Brandeis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes anti-infective products | Health Technology |
Pharmanex, Inc.
Pharmanex, Inc. Food RetailRetail Trade Provides dietary supplements products | Retail Trade |
Merck Sharp & Dohme (I.A.) Corp. (Taiwan) | |
Fu Jen Catholic University
Fu Jen Catholic University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OBI Pharma, Inc.
OBI Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures anti-infective and immunotherapy drugs | Health Technology |
Ansun Biopharma, Inc.
Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Delos Advisors Ltd.
Delos Advisors Ltd. Investment ManagersFinance Delos Capital invests in companies located in Greater China and in the United States. The firm targets companies operating in the fields of life sciences, therapeutics and medtech devices sectors. It provides financing for buyout, direct or indirect private equity investments, restructuring, recapitalizations, strategic investments and growth stage capital requirements. It also makes investments in public listed companies. | Finance |
















